Loading
Californian maker of PCR test kits whose CRCdx RAS test is an FDA companion diagnostic for panitumumab.
EntroGen makes real-time PCR reagents, automation and software for molecular laboratories. Its CRCdx RAS Mutation Detection Assay Kit was approved by the FDA in September 2023 as the companion diagnostic for panitumumab in KRAS and NRAS wild-type colorectal cancer.
A PCR test that confirms a bowel cancer has no KRAS or NRAS mutation before panitumumab.
Shares Companion diagnostics, Colorectal cancer.
Shares Companion diagnostics, Colorectal cancer.
Shares Companion diagnostics, Colorectal cancer.
Shares Companion diagnostics, Colorectal cancer.
Shares Companion diagnostics, Colorectal cancer.
Shares Companion diagnostics, Colorectal cancer.
Shares Companion diagnostics, Colorectal cancer.
Shares Companion diagnostics, Colorectal cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/